Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
주식 순위 #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
주가
$0.12164306
마지막 동기화: 2024-11-11
시가총액
$38.53M
변동 (1일)
-4.14%
변동 (1년)
0.00%
국가
AU
거래 PharmAust Limited (PAA)

카테고리

PharmAust Limited (PAA)의 주식 분할 이력
PharmAust Limited 주식 (심볼: PAA)은 총 4회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Feb 20, 2019에 발생했습니다.
Nov 15, 2004 이전에 매수한 PAA 주식 1주는 현재 0.011443846153846주의 PAA 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2019-02-20 551:500 x1.102 x0.011443846153846
2016-11-10 27:26 x1.0384615384615 x0.010384615384615
2015-10-30 1:20 x0.05 x0.01
2004-11-15 1:5 x0.2 x0.2
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH